5-Bromopyridine-3-boronic acid

• Catalog No.: 686816
• CAS Number: 452972-09-7
• M. F.: C5H5BBrNO2
• M. W.: 201.8137
• Purity: ≥95%

SYNONYMS

• Title: 5-溴吡啶-3-硼酸
• IUPAC name: (5-bromopyridin-3-yl)boronic acid
• IUPAC Traditional name: 5-bromopyridin-3-ylboronic acid
• Synonyms: (5-Bromo-3-pyridyl)boronic acid; (3-Bromopyridin-5-yl)boronic acid; (5-bromo-3-pyridinyl)boronic acid

DATABASE IDS

• CAS Number: 452972-09-7
• MDL Number: MFCD02685634

PROPERTIES

• Empirical Formula (Hill Notation): C5H5BBrNO2
• Purity: ≥95%
• Melting Point: 260 (dec.)
• GHS Signal Word: Warning
• GHS Hazard statements: H315-H319-H335
• European Hazard Symbols: Irritant (Xi)
• Personal Protective Equipment: dust mask type N95 (US), Eyeshields, Gloves
• GHS Precautionary statements: P261-P305 + P351 + P338
• Risk Statements: 36/37/38
• Safety Statements: 26-36
• Storage Temperature: 2-8°C
• German water hazard class: 3

DETAILS

Description (English)

General description
May contain varying amounts of anhydride.
Packaging
1, 5 g in glass bottle
Application
Reactant for preparation of:
• Thienylpyridyl garlands via cross-coupling with heteroaryl halides1
• Arenes via nickel-catalyzed cross-coupling with potassium aryl- and heteroaryl trifluoroborates2
• Meso-substituted ABCD-type porphyrins by functionalization reactions3
• Analogs of (acetylamino)(dimethylpyrazol)(pyridyl)pyrimidines as A2A adenosine receptor antagonists for the treatment of Parkinson′s disease4
• 5-hydroxy-1,3,2-dioxaborolan-4-ones boronate-amine complexes via heterocyclization with α-oxocarboxylic acids followed by subsequent complexation5
• Radioligands with optimized brain kinetics for PET imaging of nAChR6

Description (简体中文)

General description
可能含不定量的酸酐。
包装
1, 5 g in glass bottle
Application
Reactant for preparation of:
• Thienylpyridyl garlands via cross-coupling with heteroaryl halides1
• Arenes via nickel-catalyzed cross-coupling with potassium aryl- and heteroaryl trifluoroborates2
• Meso-substituted ABCD-type porphyrins by functionalization reactions3
• Analogs of (acetylamino)(dimethylpyrazol)(pyridyl)pyrimidines as A2A adenosine receptor antagonists for the treatment of Parkinson′s disease4
• 5-hydroxy-1,3,2-dioxaborolan-4-ones boronate-amine complexes via heterocyclization with α-oxocarboxylic acids followed by subsequent complexation5
• Radioligands with optimized brain kinetics for PET imaging of nAChR6